the nonbioenergetic capabilities of the organelle. Five noncanonical mitochondrial capabilities are centrally involved in the form-function dynamic of the mitochondria (Fig. 2) . These relationships are bidirectional, meaning they both alter and are altered by mitochondrial dynamics. First, mito chondria are linked to the endoplasmic reticulum at specialized regions of membrane adherence called mitochondriaassociated membranes, which facilitate calcium flux into the mitochondria. Mitochondriaassociated endoplasmic reticulum membranes allow localized increases in cal cium levels to propagate throughout a cell in wavelike patterns. 49 This endoplasmic reticulum-mito chondria connection has implications for calcium homeostasis and metabolism. Close coupling of these organelles increases mitochondrial calcium levels, which may initiate apoptosis 50 or, at physi ologic levels, enhance oxidative metabolism by ac tivating pyruvate dehydrogenase. 51 Mitochondriaendoplasmic reticulum connectivity is regulated by mitofusin2 and can create microdomains that facilitate fission 9,27 (Fig. 2B, inset) .
Second, mitochondrial numbers are regulated by mitochondrial biogenesis to meet the energy demands of the cell and compensate for cell dam age. This process is mediated by peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), which is relevant to mitochondrial dynamics since it is a transcriptional coactivator of the fusion mediator mitofusin2 (Table 1) . 12, 29 Third, mitochondria have a qualitycontrol program called mitophagy. Mitophagy maintains cellular health by selectively enclosing damaged, depolarized mitochondria in autophagic vacuoles for elimination by lysosomes (Fig. 3A) . 52, 53 Fission isolates depolarized mitochondria while coordi nated downregulation of fusion mediators pre vents network reintegration, thereby facilitating mitophagy.
Fourth, mitochondria actively traverse the cytosol on dynein and kinesin tracks. 54 It is un certain whether mobility and mitochondrial dy namics have an obligatory relationship; however, dynein, a molecular motor for mitochondrial transport, also regulates fission. 55 Fifth, mitochondria are oxygen sensors in cells within the homeostatic oxygensensing system, such as pulmonary arterial and ductus arterio sus smoothmuscle cells. 56 These specialized mitochondria vary production of diffusible reac tive oxygen species by the electron transport chain in proportion to cellular oxygen levels, permitting redox regulation of ion channels, enzymes, and transcription factors. 56 Mitochon drial dynamics are an early step in this redox signaling mechanism. 10, 23 Fission creates smaller, more discrete mito chondria, which, depending on the context, are more capable of generating reactive oxygen spe cies, facilitating mitophagy, or accelerating cell proliferation. Fusion results in a more intercon nected mitochondrial network that enhances communication with the endoplasmic reticulum. Fusion also allows diffusion of matrix content among mitochondria ( Fig. 2A) , diluting the ac cumulated mitochondrial DNA mutations 57 and oxidized proteins. Both fission and fusion are mediated by a small number of highly conserved, guanosine triphosphatases (GTPases) 58, 59 ( Fig. 2 and Table 1 ). Fission is mediated by dynamin related protein 1 (DRP1), 60,61 a cytosolic protein that on activation translocates to the outer mito chondrial membrane. Here, DRP1 multimerizes, creating a ringlike structure that constricts and divides the organelle 21,22 (Fig. 2B ). Video 1, avail able at NEJM.org, shows the dynamic nature of fission and fusion when a photoactivated green fluorescent protein-labeled mitochondrion divides (fission) and then fuses with a red fluorescent protein-labeled mitochondrion to create a fused yellow mitochondrion. DRP1 is actively targeted to the outer mitochondrial membrane by non GTPase receptor proteins such as mitochondrial fission protein 1 (Fis1), 22 mitochondrial fission factor (MFF), 25 and mitochondrial elongation factor 1 26 ( Fig. 2B and Table 1 ). Assembly of the fission apparatus is assisted by the endoplasmic reticulum, which contacts the mitochondria, cre ating a microdomain for assembly of DRP1, MFF, and proapoptotic proteins 62 (Fig. 2B and 3A) .
DRP1 activity is rapidly regulated by the op posing effects of phosphorylation at two key serines. Phosphorylation of serine 616 increases DRP1 activity, whereas phosphorylation of serine 637 decreases it. Each serine is targeted by dif ferent kinases and phosphatases, thereby linking mitochondrial fission to crucial cellular pro cesses ( Fig. 2B, inset; and Table 1 ). For example, phosphorylation of serine 616 by the mitosis ini tiator, cyclin B1-cyclindependent kinase (cyclin B1-CDK1), activates DRP1 coordinating fission to cell division 23, 32 (Fig. 3B ), whereas phosphory lation by calciumcalmodulin-dependent kinase (CamK) links fission to intracellular calcium. 34 Phosphorylation of serine 637 by protein kinase A inactivates DRP1 63 ; conversely, dephosphorylation of serine 637 by the calciumsensitive protein phos phatase, calcineurin, activates DRP1 ( Fig. 2B and Table 1 ). The ratio of serine 616 to serine 637 phos phorylation determines DRP1 activity and re flects the aggregate effects of many kinases and phosphatases (Fig. 2) . DRP1 activity is also posttranslationally regulated by the ubiquitin ligase membrane-associated RINGCH protein 5 (MARCH5) 38 and by small ubiquitinlike modi fier type 1 (SUMO1) 37 (Table 1 and Fig. 2B ). Our understanding of the role of DRP1 and fission in disease states has been advanced by the avail ability of mitochondrial division inhibitor 1 (mdivi1), a small molecule that inhibits the GTPase activity of DRP1, prevents multimeriza tion, and inhibits fission. 64 Fusion is mediated by mitofusin1 and mito fusin2 isoforms in the outer mitochondrial mem brane and by optic atrophy 1 (OPA1) protein in Hypoxic transcription factor that also promotes DRP1 activation and fission (mech anism uncertain) Unknown Pulmonary arterial hypertension, 9,10 cancer The permeable outer mitochondrial membrane and impermeable inner membrane are separated by an intermembrane space into which hydrogen ions (H+) are pumped during electron transport. Within the inner mitochondrial membrane is a matrix containing mitochondrial DNA, proteins, and ribosomes. Within the cristae reside the four electron transport chain megacomplexes and the ATP-synthase, where ADP and inorganic phosphate (P I ) are joined to make ATP. Pyruvate generated in the cytosol by glycolysis either enters the mitochondria and fuels oxidative metabolism or remains in the cytosol and is converted to lactate by lactate dehydrogenase (LDH) if mitochondrial metabolism is inhibited. Once inside the mitochondria, pyruvate is converted into acetyl coenzyme A (CoA) by pyruvate dehydrogenase (PDH), the major regulator of oxidative metabolism. PDH can be inhibited by pyruvate dehydrogenase kinase (PDK) or activated by increases in mitochondrial calcium. Acetyl CoA fuels the Krebs cycle and generates electron donors (NADH and flavin adenine dinucleotide), which pass electrons down the electron transport chain to reduce molecular oxygen. This electron flux generates the chemiosmotic hydrogen ion gradient that powers ATP synthesis. In addition, electron flux generates reactive oxygen species such as superoxide anion (O 2 −), which are converted to the diffusible redox signaling molecule hydrogen peroxide (H 2 O 2 ) by superoxide dismutase 2 (SOD2). Mediators of fusion (mitofusin-1 and mitofusin-2) and the enzyme that generates fusogenic lipids, phospholipase D, reside in the outer mitochondrial membrane, whereas optic atrophy 1 (OPA1) is located in the inner membrane. The fission mediator DRP1 is located in the cytosol, but when it is activated, as it is after phosphorylation (P) at serine 616, it translocates to the outer mitochondrial membrane. The cell cycle and mitochondrial fission are linked by cyclin B1-cyclin-dependent kinase (CDK), ensuring coordination of nuclear and mitochondrial division. Peroxisome-proliferator-activated receptor γ coactivator 1α (PGC-1α) and hypoxia-inducible factor 1α (HIF-1α) also provide transcriptional control of fission and fusion. Calcium moves from the endoplasmic reticulum to mitochondria through membrane-adherence zones called mitochondria-associated endoplasmic reticulum membranes (MAMs). Mitochondrial calcium levels regulate PDH activity and apoptosis. The mitochondria and endoplasmic reticulum also interact to create microenvironments that direct fission.
The Panel A shows how mitochondria join through the process of fusion, which is mediated by the coordinated activities of mitofusins in the outer mitochondrial membrane and OPA1 in the inner mitochondrial membrane. The mitochondrial matrix contains red or green fluorescent proteins. When mitochondria fuse, their matrix materials intermix, creating elongated organelles that appear yellow. The inset shows how the two mitofusin isoforms form homodimers or heterodimers that tether adjacent mitochondria, promoting fusion by a hook-and-loop mechanism that is similar to a Velcro fastener. Panel B shows how fission occurs when DRP1 is activated and moves from the cytosol to the outer mitochondrial membrane. Assembly of the fission apparatus is guided by targeting molecules in the outer mitochondrial membrane (mitochondrial fission factor [MFF] and mitochondrial fission 1 protein [Fis1] ) that are aggregated in a microenvironment shaped by contact with the endoplasmic reticulum. Activation usually reflects post-translational modification by a kinase, phosphatase, or ubiquitin ligase, or by alteration of sumoylation. For example, calcium-calmodulin-dependent kinase (CamK) and cyclin B1-CDK1 phosphorylate and activate DRP1. Nitric oxide may activate DRP1 by means of nitrosylation. The nucleolar small ubiquitin-like modifier (SUMO) protease sentrin-specific peptidase 5 (SENP5) can activate DRP1 by means of desumoylation. Membrane-associated RING-CH protein 5 (MARCH5) and parkin are ubiquitin ligases that can regulate DRP1 activation and degradation. Mitochondrial dynamics protein 49 kD (M:D49) and mitochondrial dynamics protein 51 kD (M:D51), which are located in the mitochondrial outer membranes, form division-inducing rings around mitochondria. The formation of rings that cause fission is a property shared by DRP1. Protein kinase A (PKA) phosphorylates DRP1 at serine 637, which inactivates the enzyme; conversely, calcineurin reverse-dephosphorylates this serine, which activates DRP1. The insets show confocal micrographs in which color coding identifies discrete mitochondria. The normal airway epithelial cell has fused mitochondria, and its cancerous counterpart, an A549 lung-cancer cell, shows evidence of mitochondrial fission. Bax denotes Bcl-2-like protein 4, ROCK1 Rho-associated, coiled-coil-containing protein kinase 1, MAPL mitochondrial-anchored protein ligase, SNO S-nitrosylated Drp1, and Ub ubiquitin. Adapted from Rehman et al. 
Proliferative, Apoptosis-Resistant Diseases

Cancer
Excessive proliferation and resistance to apoptosis are hallmarks of cancer cells (Fig. 4A ). 69 These hallmarks reflect, in part, acquired abnormalities of mitochondrial function, notably a shift from oxidative metabolism to aerobic glycolysis (the War burg effect). 70 This metabolic phenotype primarily reflects activation of mitochondrial pyruvate de hydrogenase kinase, which inhibits pyruvate dehy dro g enase and suppresses oxidative metabolism, rendering the cell apoptosisresistant ( Fig. 1 ). These functional mitochondrial abnormalities offer po tential therapeutic targets. Restoring pyruvate de hydrogenase activity and oxidative metabolism in hibits proliferation, induces apoptosis, and shrinks human tumors in xenotransplantation models 41 and in patients. 71 Structural mitochondrial abnor malities also contribute to the imbalance between proliferation and apoptosis in cancer. 11 Impaired fusion and enhanced fission fragment the mito chondrial network in lung adenocarcinoma in humans 11 (Fig. 4A) . 
Figure 3 (facing page). Noncanonical Functions of Mitochondria Related to Mitochondrial Dynamics.
Panel A shows mitochondrial function in nonmitotic cells. Mitochondria are actively regulated to prevent cell damage and death. Several responses can be deployed, sequentially or in tandem, to protect cells. For instance, PGC-1α-mediated mitochondrial biogenesis increases mitochondrial numbers and replaces damaged mitochondria. In addition, mitofusin-mediated fusion dilutes damage that accumulates in the mitochondria, including mitochondrial DNA mutations and oxidized proteins. When mitochondrial damage exceeds a critical level, DRP1-mediated asymmetric fission supports mitochondrial quality control. DRP1 divides a mitochondrion into a larger, polarized healthy portion (which can reintegrate with the network) and a smaller depolarized, abnormal portion. These depolarized mitochondrial segments have lower levels of fusion mediators, such as OPA1, preventing reincorporation into the network. This isolates the diseased mitochondria, allowing them to be packaged into autophagic vacuoles that are transported to lysosomes for elimination by mitophagy. These responses are beneficial only when they operate at a physiologic level. Excessive fission causes cell death, whereas excessive mitophagy causes autophagic stress; both promote cell damage and death. Mitochondria-endoplasmic reticulum interactions occur at sites of imminent fission, creating a microdomain for assembly of the fission apparatus. 27 Panel B shows a dividing cell. Mitosis is coordinated with mitochondrial division to ensure the equitable distribution of mitochondria to daughter cells; this process is called mitotic fission. Although several kinases, including aurora kinases, are involved, the role of cyclin B1-CDK1 has been studied most extensively. Cyclin B1-CDK1 simultaneously promotes nuclear division (mitosis) and phosphorylates and activates DRP1 at serine 616, causing fission. Ubiquitination and sumoylation also regulate mitotic fission.
37 During mitosis, SENP5, a nucleolar SUMO protease, moves to the mitochondria, where it desumoylates and activates DRP1.
37 After mitosis, ubiquitination by the anaphase-promoting complex (cyclosome) and its coactivator cadherin 1 (APC-Cdh1) marks DRP1 for proteosomal degradation, allowing G1-phase reassembly of mitochondrial networks. 44 If mitochondria are forced to remain fused (through inhibition of DRP1-using small interfering RNA [siRNA] or mitochondrial division inhibitor 1 [mdivi-1] or through augmentation of mitofusin-2), the cell cycle is arrested in the G2-M phase and the cells tend to be eliminated by apoptosis. Thus, mitotic fission is a cell-cycle checkpoint and inhibition of mitotic fission impairs cell-cycle progression.
relates to the requirement for mitochondrial di vision during mitosis. This coordination between mitochondrial division and mitosis (socalled mitotic fission) ensures equitable distribution of mitochondria to daughter cells 32,43 (Fig. 3B) . The molecular basis for the coordination of mito chondrial and nuclear division is emerging. At the transition from the G1 phase to the S phase, mitochondria fuse and increase ATP produc tion. 43 DRP1 inhibition induces mitochondrial hyperfusion and triggers DNA replication and cyclin E accumulation. 43 The coordination of fis sion and mitosis is substantially regulated by cyclin B1-CDK1, which simultaneously initiates mitosis and activates DRP1 by phosphorylating serine 616 11 (Fig. 2B) . Another mitotic kinase, aurora A, phosphorylates the Raslike GTPase (RalA), leading to mitotic, mitochondrial accu mulation of RalA and its effector, ralA binding protein 1 (RalBP1). RalBP1 serves as a scaffold for recruiting DRP1 and cyclinCDK to mito chondria and inducing fission. 33 Increased fission in lungcancer cells and tu mors from patients who have not received treat ment reflects posttranslational DRP1 activation, manifested by an increased ratio of serine 616 to serine 637 phosphorylation. 11 In patients with lung cancer, increased DRP1 expression predicts a likelihood of recurrence that is increased by a factor of 3.4, as well as a greater likelihood of cisplatin resistance. 24 Impaired fusion, resulting from downregulation of mitofusin2, also con tributes to network fragmentation. 11 Mitochon drial fragmentation contributes to the cancer phenotype in several ways. Fragmentation may accelerate mitotic fission 11 and also interrupts intramitochondrial calcium waves, preventing calciummediated apoptosis. 50 Inhibition of DRP1 or augmentation of mitofusin2 decreases prolif eration and increases apoptosis in cancer cells and leads to regression of human lung tumors in a xenotransplantation model 11 (Fig. 4A) .
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (Fig. 4B) is an obstructive pulmonary vasculopathy. Although vasoconstriction, inflammation, and thrombosis contribute to the pathogenesis, an "oncologic view" is emerging, which holds that excessive prolifer ation and impaired apoptosis mediate disease pro gression. 17 Many factors contribute to the neoplastic phenotype of pulmonary arterial hypertension. 18,72 Both oxygensensing and mitochondrial dynam ics are disordered in pulmonaryartery smooth muscle cells, as indicated by normoxic activation of hypoxiainducible factor 1α (HIF1α) and mito chondrial fragmentation. 19 The fingerprint of mito chondrial dynamics in pulmonary arterial hyper tension is similar to that in cancer, with reduced mitofusin2-mediated fusion 12 and excessive DRP1 mediated fission. 23 These acquired defects reflect both transcrip tional and posttranslational abnormalities. Tran scriptional abnormalities include increased HIF1α
The Cancer and pulmonary arterial hypertension are syndromes of excess proliferation and apoptosis resistance which share fragmented mitochondria relating to excess DRP1 and deficient mitofusin-2
Arterial restenosis (carotid):
• Mitofusin-2 deficiency promoting proliferation of smooth-muscle cells
Ischemia-reperfusion injury (heart):
• DRP1 activation (decreased serine 637 phosphorylation)
• Excessive mitochondrial fission • Increased production of ROS and elevated calcium promotes diastolic cardiac dysfunction
Diabetes (liver and pancreas):
• Loss of OPA1, mitofusins, or both
• Impaired fusion compromises bioenergetics, reducing mitochondrial biogenesis and oxygen consumption
Mutation:
• OPA1 mutation (autosomal dominant)
Clinical manifestations:
• Temporal pallor of optic disk on fundoscopy
Cellular features:
• Impaired fusion with increased susceptibility to neuronal apoptosis
Mutation:
• Mitofusin-2 mutation
Clinical manifestations:
• Peripheral neuropathy
• Stork-leg deformity
• Abnormal gait
Cellular features:
• Impaired mitochondrial movement to synapse and associated impaired neuronal bioenergetics
Mutation:
• PINK1 or parkin mutations (inheritable juvenile disease)
Clinical manifestations:
• Rigidity
Cellular features:
• Excessive DRP1-mediated fission 2245 activation 23,31 and decreased PGC1α activity. 12 Activation of HIF1α in normal pulmonary artery smoothmuscle cells is sufficient to cause DRP1dependent mitochondrial fission. 23 The normoxic HIF1α activation in pulmonary arterial hypertension leads to a proliferative, apoptosis resistant milieu through both metabolic effects (pyruvate dehydrogenase inhibition) and induc tion of a fission-fusion imbalance; the latter mechanism is not well understood. 17 Posttranslational abnormalities (increased cy clin B1-CDK1-dependent and CamKdependent DRP1 phosphorylation) activate DRP1 and pro mote fission. 23 Many of these profission, anti fusion abnormalities occur in models of pulmo nary arterial hypertension created in healthy rats and persist in cell culture, suggesting epigenetic underpinnings. 17 Mitofusin2 levels are reduced in pulmonary arterial hypertension, contributing to both mito chondrial fragmentation and the proliferative diathesis. 12 Mitofusin2 was originally named the
Figure 4 (facing page). Mitochondrial Diseases in Humans.
Fission and fusion imbalances in diseases are characterized by excessive proliferation and resistance to apoptosis. In Panel A, a patient with non-small-cell lung cancer and her chest computed tomographic scan are shown (left). The micrographs (middle) show mitochondrial fragmentation in the cancer cells. This fragmentation results from a fission-fusion mediator profile favoring fragmentation (excess total and activated DRP1 and deficient mitofusin-2). The elevated ratio of serine 616 to serine 637 phosphorylation of DRP1 reflects DRP1 activation and may be a useful cancer biomarker. Mitotic fission is a potential vulnerability of cancer cells and offers many new therapeutic targets. DRP1 inhibition by means of mdivi-1, 8 small inhibitory DRP1 RNA (si-DRP1), 11,66 or adenoviral mitofusin-2 fuses mitochondria, inhibits proliferation, induces apoptosis, and regresses human lung cancers in a xenotransplantation model 11 (right). The mitochondrial fragmentation in cancer and the therapeutic effects of mdivi-1 are shown in Videos 2, 3, and 4, which show a normal airway epithelial cell (Video 2), a lung-cancer cell (Video 3), and a lung-cancer cell treated for 16 hours with mdivi-1 (Video 4). In Panel B, a patient with pulmonary arterial hypertension is shown (left). A magnetic resonance imaging angiogram shows pruning of distal pulmonary arteries. RV denotes right ventricle, and PA pulmonary artery. The loss of pulmonary arteries reflects obstruction by complex arterial lesions (as shown in the histologic specimens). Arteriopathy is due in part to the presence of hyperproliferative, apoptosis-resistant pulmonary-artery smooth-muscle cells (PASMCs) (middle). These cells share with cancer cells the features of mitochondrial fragmentation and fission-fusion imbalance. They also overexpress activated DRP1 and underexpress mitofusin-2. Increased expression of cyclin B1-CDK1 in pulmonary arterial hypertension activates DRP1 by phosphorylating it at serine 616. The fundamental cause of the fragmentation is multifactorial and includes normoxic activation of HIF-1α and a deficiency of PGC-1α. Preventing mitotic fission with the use of mdivi-1 or si-DRP1 causes cell-cycle arrest at the G2-M checkpoint in pulmonary arterial hypertension PASMCs.
11 Despite having doubled their DNA content, PASMCs treated with a DRP1 inhibitor cannot complete mitosis and are removed by means of apoptosis.
23 The mitochondrial fragmentation in pulmonary arterial hypertension and the therapeutic affects of mdivi-1 are shown in Videos 5, 6, and 7, which show a normal smooth-muscle cell (Video 5), a PASMC obtained from a patient with pulmonary arterial hypertension (Video 6), and a PASMC (also obtained from a patient with pulmonary arterial hypertension) treated for 16 hours with mdivi-1 (Video 7). Increased levels of cytosolic calcium in pulmonary arterial hypertension may promote fission by activating calcineurin (which dephosphorylates DRP1 serine 637) 35 and CamK (which activates DRP1 in neurons 34 ). Although the calcineurin inhibitor cyclosporine causes experimentally induced pulmonary arterial hypertension to regress, 17 it is not known whether this relates to effects on mitochondrial dynamics. Likewise, it is unknown whether CamK-II, the predominant vascular isoform, activates DRP1. Inhaled adenoviral mitofusin-2 and mdivi-1 enhance exercise performance and partially regress experimentally induced pulmonary arterial hypertension in rats, as judged by exercise capacity (bar graph at right).
12,23 Although the relative prevalence of disordered mitochondrial dynamics and its biologic importance in sporadic neurodegenerative diseases are uncertain, heritable conditions indicate the biologic plausibility that increased fission and decreased fusion can be toxic to neurons. As shown in Panel C, heritable juvenile parkinsonism results from autosomal recessive mutations in PINK1 42 or parkin. 45 The PINK1-parkin pathway normally maintains a fused mitochondrial network, 40 reduces mitochondrial oxidant stress, prevents fission, and maintains normal mitochondrial membrane potential. Preclinical data suggest that strategies that inhibit fission, enhance fusion, or selectively restore mitophagy may have therapeutic benefit in this form of parkinsonism and other neurodegenerative syndromes such as Huntington's disease. As shown in Panel D, Charcot-Marie-Tooth disease is an inherited peripheral neuropathy.
67
There are two types of Charcot-Marie-Tooth disease. Type 1 primarily affects Schwann cells and is associated with slow nerve conduction, whereas type 2 affects motor neurons and is associated with normal nerve conduction. The axonal subtype, type 2A, usually results from autosomal dominant loss-of-function mutations in mitofusin-2. Mitofusins can form homodimers or heterodimers. Mitofusin-1 (but not mitofusin-2) can rescue mutant mitofusin-2; this suggests that variability in mitofusin-1 expression could underlie disease heterogeneity and that modulating neuronal mitofusin-1 expression might have a therapeutic role.
68 Panel E shows autosomal dominant optic atrophy, a heritable form of blindness that results from mutation and loss of function of OPA1. Reproduced from Olichon et al.
14 with the permission of the publisher. Panel F shows cardiometabolic diseases such as arterial restenosis. Mitofusin-2 expression is reduced in models of arterial injury; this contributes to intimal proliferation and restenosis. Mitofusin-2 augmentation might be a useful strategy for reducing restenosis in systemic arteries.
7 Ischemia-reperfusion injury is characterized by increased fission. DRP1 inhibition, whether achieved directly (by administering mdivi-1 or siDRP1) or indirectly (by preventing dephosphorylation of DRP1 serine 637 with the use of therapeutic hypothermia or the calcineurin inhibitor FK506), may be cardioprotective.
36 Impaired fusion due to reduced mitofusin-2 and its transcriptional coactivator PGC-1α may contribute to diabetes and the metabolic syndrome. However, simply augmenting fusion is unlikely to be effective, since excessive fusion can interfere with beneficial mitophagy. "hyperplasiasuppressor gene" 7 because of its anti proliferative effects on systemic arterial smooth muscle cells. 7 Mitofusin2 downregulation in pul monary arterial hypertension is associated with low levels of PGC1α, 12 the transcriptional coacti vator of mitofusin2. 73 Preclinical testing showed that augmenting mitofusin2 decreases prolifera tion and increases apoptosis of pulmonaryartery smoothmuscle cells and leads to partial regres sion of experimentally induced pulmonary arte rial hypertension in vivo in rats. 12 Although this therapeutic benefit is associated with restoration of fusion, the link between fusion and inhibition of proliferation is controversial. In systemic arte rial cells, truncated mitofusin2 variants that do not localize to mitochondria retain antiprolifera tive properties by inhibiting extracellular signal regulated and mitogenactivated protein kinases. 7
Patent Ductus Arteriosus
Functional ductus arteriosus closure is initiated by oxygendependent vasoconstriction within minutes after birth. An increase in oxygen is ac companied by increases in oxidative metabolism, electron transport chain activity, and generation of reactive oxygen species. Reactive oxygen spe cies are converted by mitochondrial superoxide dismutase 2 (SOD2) to hydrogen peroxide, a dif fusible oxidant messenger that regulates ion channels and enzymes, thereby initiating ductal constriction. 56 A subsequent fibrogenic, prolif erative mechanism results in anatomical closure. Recently, it was discovered that the redox sensing mechanism of the human ductus arte riosus relies on mitochondrial fission. Within 5 minutes after an increase in oxygen, DRP1 mediated fission fragments ductus arteriosus smoothmuscle cell mitochondria. 10 Inhibiting DRP1 selectively prevents oxygeninduced ductal constriction. Oxygen induces fission by cyclin B1-CDK1-dependent and CamKdependent, post translational DRP1 activation. 10 In ductus arterio sus smoothmuscle cells, fission activates pyruvate dehydrogenase and increases electron transport chain complex 1 activity, creating an oxidant environment. Conversely, inhibiting fission in terrupts redox signaling, preventing oxygen dependent production of mitochondrialderived hydrogen peroxide. This link between structure and electron transport chain assembly and activity is similar to an observation made in drosophila, in which a knockout of PINK1 (phosphatase and tensin homologue-induced putative kinase 1) im pairs fission and reduces bioenergetic capacity by causing defective electron transport chain com plex assembly. 74 Although sustained DRP1 inhi bition prevents anatomical closure in an ex vivo human ductus arteriosus model, it is not known whether impaired mitochondrial fission contrib utes to spontaneous patent ductus arteriosus.
Neurodegenerative Diseases
Neuronal development requires both DRP1 75 and mitofusin2. 76 Neuronal DRP1 knockout causes mitochondrial maldistribution, apoptosis, and perinatal death due to brain hypoplasia (Fig. 4C,  4D, and 4E) . 75 The beneficial role of DRP1induced fission in human brain development is highlighted by the description of an infant with a dominant negative DRP1 mutation. 16 She had hypotonia, microcephaly, and optic atrophy and died sud denly at 37 days of age; studies showed impaired mitochondrial metabolism and hyperfusion, which were consistent with impaired fission. 16 Al though some level of fission is required for brain development, increased fission and impaired fu sion, resulting in mitochondrial fragmentation, are the rule in adult neurodegenerative diseases.
Familial Parkinsonism
Parkinson's disease is a neurodegenerative syn drome characterized by resting tremor, rigidity, and bradykinesia, resulting from death of dopa minergic neurons in the substantia nigra. Although most cases of parkinsonism are sporadic, rare her itable, juvenile cases result from autosomal reces sive mutations in mitochondrialtargeted kinases PINK1 58 and parkin 59 (Table 1 and Fig. 4C ).
PINK1, a serine-threonine kinase, protects neu rons by preventing stressinduced mitochondrial depolarization and apoptosis 42 and reducing mitochondrial oxidative stress and fission. 39 PINK1 also phosphorylates parkin, targeting it to depolarized mitochondria and thereby en hancing mitophagy. 77 Parkin, a ubiquitin E3 li gase, protects neurons by ubiquitinating pro teins that are abnormal in structure or quantity (including DRP1 46 ), marking them for proteoso mal degradation. Parkin also ubiquitinates dys functional mitochondria, leading to their removal by mitophagy. 78 PINK1 and parkin lossoffunction mutations have complex effects; however, increased DRP1mediated mitochondrial fission is an im portant consequence and contributes to neuro 2247 nal death. 46, 79, 80 Neurons lacking PINK1 or par kin accumulate DRP1, and the resulting excessive fission increases oxidative stress and reduces ATP production. 39, 40, 81 These neurons can be rescued by inhibiting fission with the use of mdivi1 82 or by enhancing fusion through aug mentation of mitofusin2 or OPA1. 39, 40, 81 Exces sive fission is not neuronally restricted; it is de tected in dermal fibroblasts from patients. 41 How this relatively generalized abnormality of mito chondrial dynamics results in tissuerestricted disease is an unresolved mystery that is relevant to optic atrophy and Charcot-Marie-Tooth dis ease type 2A. PINK1 and parkin also regulate mitophagy. The relationship between mitochondrial dynamics and mitophagy is uncertain; however, the auto phagic machinery both delivers mitochondria to lysosomes and contributes to mitochondrial fragmentation 39 (Fig. 3A) . At physiologic levels, both mitochondrial fission and mitophagy are beneficial, working together to eliminate dam aged and depolarized mitochondria 39 ; however, an excess of either process leads to cell death.
Two pesticides that promote parkinsonism (the electron transport chain complex 1 inhibitor rotenone 83 and paraquat 84 ) induce mitochondrial fragmentation. Rotenone and paraquat initiate parkinmediated mitochondrial depolarization. They then trigger fragmentation by promoting mitofusin degradation, through a proteosomal mechanism mediated by the AAA+ superfamily of ATPases and valosincontaining protein p97. 47 The AAAfamily ATPases interact with p97 to com pose a ubiquitin-proteosome pathway that extracts proteins such as mitofusin2 from the outer mi tochondrial membrane into the cytosol, where they ultimately undergo proteosomal degradation. Removing mitofusins from the outer mitochon drial membrane inhibits fusion and prevents abnormal mitochondria from re integrating into the network, thereby facilitating mitophagy. 47 This socalled outer mitochondrial membraneassociated degradation pathway 47 mediates mi tochondrial quality control and is analogous to the endoplasmic reticulum qualitycontrol path way (ERAD). 85 
Alzheimer's Disease
The most common cause of dementia is Alz hei mer's disease, which is characterized by accumu lation of amyloid plaques, neurofibrillary tangles, and loss of connections between neurons. In one study, βamyloid increased neuronal nitric oxide, generating Snitrosylated, activated DRP1, which caused fission and neuronal damage. 86 Inhibi tion of DRP1 nitrosylation reduced neurotoxicity. However, a subsequent investigation could nei ther replicate the effects of Snitrosylation on DRP1 activity nor support a role for this mecha nism in Alzheimer's disease. 87 
Huntington's Disease
An autosomal dominant disease characterized by choreoathetosis, dementia, and premature death, Huntington's disease results from expansion of a CAG trinucleotide DNA sequence encoding a polyglutamine tract in the huntingtin protein. 88 The polyglutamine accumulation causes protein misfolding and promotes abnormal protein in teractions. Mutant huntingtin interacts with and activates DRP1, increasing fission and neuronal sensitivity to apoptosis in rat neurons and in fi broblasts from patients with Huntington's dis ease. 20 The severity of CAG expansion in the hun tingtin gene, an established predictor of disease severity, also predicts the severity of fission. 88 The importance of polyglutaminecontaining proteins for fission and cell death is recapitulated in cellular and Caenorhabditis elegans models of Huntington's disease. 88 In both models, inhibit ing DRP1 or augmenting mitofusin2 restores mitochondrial fusion, preserves ATP, and pre vents cell death. 88 
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis is a motor neuron disease that causes weakness and death. In a rare heritable form of the disease, mutation of super oxide dismutase 1 causes DRP1mediated fission, which inhibits axonal transport of mitochondria, causing neuronal death. 89 The mitochondrial matrix sirtuin SIRT3 and PGC1α provide protec tion against excessive fission and neuronal death.
Neuropathies
Charcot-Marie-Tooth Disease
An inherited peripheral neuropathy, Charcot-MarieTooth disease (Fig. 4D) 
Cardiometabolic Diseases
Diabetes Mellitus
Mitochondrial fusion defects promote diabetes in murine models of type 1 diabetes mellitus. In patients with obesity or type 2 diabetes mellitus (Fig. 4F) , fusion is also impaired, as evidenced by reduced mitofusin2 expression and decreased mi tochondrial size. 30 Hepatic deletion of mitofusin2 increases reactive oxygen species generation, im pairs insulin signaling, and causes glucose intol erance. 93 Downregulation of mitofusin2 impairs oxygen consumption and promotes diabetes. Mice with pancreatic βcell-specific OPA1 knockout also have impaired glucosestimulated insulin se cretion, and hyperglycemia develops in such mice. 94 Although severe impairment of fusion promotes diabetes, tonic restoration of fusion is unlikely to be a simple remedy because some mitochon drial fragmentation is required for mitophagy. Mitochondria undergo asymmetric fission, re sulting in both normal mitochondria and depo larized, dysfunctional mitochondria that are deficient in OPA1. 95 OPA1 deficiency isolates ab normal mitochondria, preventing network re integration. This localized impairment of fusion and mitophagy is beneficial. Indeed, inhibiting mitophagy by enhancing fusion (overexpressing OPA1) leads to accumulation of damaged mito chondria with impaired respiration and reduced insulin secretion. 95
Ischemia-Reperfusion Injury
Despite effective resuscitation techniques, mor tality from cardiac arrest remains high, in part because of ischemia-reperfusion injury (Fig. 4F) . In the kidney, mdivi1 protects renal tubular cells from fission induced by ischemia-reperfusion in jury 96 ; it is also protective in a cardiac ischemiareperfusion injury model. 97 During cardiac arrest, DRP1 is activated by calcineurinmediated de phosphorylation of DRP1 at serine 637. 36 The re sulting fission increases reactive oxygen species production, increases levels of calcium, and im pairs diastolic relaxation. DRP1 inhibition, whether achieved directly or by targeting calcineurin, may have a therapeutic effect (Fig. 4F) .
Cardiomyopathy
Because germline mitofusin knockouts are lethal at the embryonic stage, tissuespecific, conditional knockout mice are required to study the role of mitofusins in the heart. Conditional cardiac abla tion of both mitofusin isoforms simultaneously has deleterious effects on mitochondrial morpho logic features, respiration, and contractile func tion, resulting in death from cardiac failure. 98, 99 Conversely, deletion of only one mitofusin isoform is cardioprotective against ischemia-reperfusion injury and reactive oxygen species. Conditional car diac deletion of mitofusin2 results in mitochon drial dysfunction and hypertrophy, both of which are mild, with a slight reduction in left ventricu lar function. However, these mice have reduced susceptibility to activation of the mitochondrial permeability transition pore. 100 The same group of investigators subsequently showed that condi tional mitofusin1 knockouts also have normal baseline cardiac function and are protected from reactive oxygen species-induced cardiotoxicity. 
Fu t ur e Dir ec tions
